|Last Price$0.07||Day Change (%)-14.83%|
|Open Price$0.07||Day Change ($)-0.01|
|Day Range0.07–0.07||52-Week Range0.07–0.15|
As of Mon 7/6/2015 10:59:00 AM | USD
Research and Markets: Global Dry Eye Syndrome Market 2015-2019 with Alcon , Allergan, Otsuka Holdings & Santen Pharmaceuticals Dominating
Research and Markets: Global Energy-Based Therapeutics Market - Industry Analysis 2015-2019: Key Vendors Are Johnson & Johnson, Lumenis & Syneron Medical
EUROPE MARKETS: European Stocks On Track For A Two-week High
European stocks on track for a two-week high
Research and Markets: United Kingdom Ophthalmic Goods & Services Market Report 2015
Alcon benefits from leadership positions across eye care.
The stocks mentioned in this article be holdings in the managed portfolios of Validea Capital Management, a separate asset management firm founded by Validea.com founder John Reese. Validea Capital Management, which an SEC registered investment advisory firm and a separate company from Validea.com, ...
Aerie Pharmaceuticals Announces that Richard A. Lewis, M.D., Has Joined as Chief Medical Officer
Four offerings deemed to be right for right now.
The company's diverse operating divisions and robust pipeline should lead to steady growth.